Alberta Health services
Quick facts
Marketed products
- Salagen · Cardiovascular
- strontium-89 · Oncology
Strontium-89 is a radioactive beta-emitting isotope that localizes to areas of increased bone metabolism and delivers targeted radiation to bone lesions.
Phase 3 pipeline
- intravenous busulfan · Oncology
Intravenous busulfan is an alkylating agent that interferes with DNA replication, leading to cell death in rapidly dividing cells.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: